| Product NDC: | 0074-9296 |
| Proprietary Name: | Synthroid |
| Non Proprietary Name: | Levothyroxine Sodium |
| Active Ingredient(s): | 112 ug/1 & nbsp; Levothyroxine Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0074-9296 |
| Labeler Name: | Abbott Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021402 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020724 |
| Package NDC: | 0074-9296-13 |
| Package Description: | 100 TABLET in 1 BOTTLE (0074-9296-13) |
| NDC Code | 0074-9296-13 |
| Proprietary Name | Synthroid |
| Package Description | 100 TABLET in 1 BOTTLE (0074-9296-13) |
| Product NDC | 0074-9296 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levothyroxine Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020724 |
| Marketing Category Name | NDA |
| Labeler Name | Abbott Laboratories |
| Substance Name | LEVOTHYROXINE SODIUM |
| Strength Number | 112 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |